Abstract
We previously reported on the outcome of 21 patients with stage IV advanced and/or recurrent tongue base carcinoma subjected to mTHPC-PDT. We continue to develop on the previous work by treating more patients with this unforgiving disease. PDT has shown to be a very successful minimally-invasive surgical tool in managing this pathology. Tumour-associated symptoms were reduced significantly. The overall morbidity and mortality following PDT, in this group of patients, were far less when compared with other conventional modalities.
Highlights
IntroductionIn a preliminary study, on the use of PDT as a minimally-invasive surgical intervention for advanced and/or recurrent tongue base carcinoma [1]
We previously reported on the outcome of 21 patients with stage IV advanced and/or recurrent tongue base carcinoma subjected to mTHPC-PDT
The overall morbidity and mortality following PDT, in this group of patients, were far less when compared with other conventional modalities
Summary
In a preliminary study, on the use of PDT as a minimally-invasive surgical intervention for advanced and/or recurrent tongue base carcinoma [1]. Twenty-one patients with this unforgiving disease were subjected to mTHPC-US-guided interstitial PDT, the cohort was followed-up for a mean of 36 months Tumour response to PDT was remarkable with the majority of the patients reporting reduction of tumour-associated symptoms (P
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
